✦ LIBER ✦
Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers
✍ Scribed by Catherine M. Kelly; Savitri Krishnamurthy; Giampaolo Bianchini; Jennifer K. Litton; Ana M. Gonzalez-Angulo; Gabriel N. Hortobagyi; Lajos Pusztai
- Book ID
- 102111087
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 211 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.